Monosodium Glutamate From China and Indonesia

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. International Trade Commission [Investigation Nos. 731-TA-1229-1230 (Second Review)] Determinations On the basis of the record  [ 1 ] developed in the subject five-year reviews, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that revocation of the antidumping duty orders on monosodium glutamate (“MSG”) from China and Indonesia would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted these reviews on October 1, 2025 ( 90 FR 47334 ) and determined on February 23, 2026, that it would conduct expedited reviews ( 91 FR 14880 , March 27, 2026). [ 2 ] The Commission made these determinations pursuant to section 751(c) of the Act ( 19 U.S.C. 1675(c) ). It completed and filed its determinations in these reviews on May 1, 2026. The views of the Commission are contained in USITC Publication 5734 (May 2026), entitled Monosodium Glutamate from China and Indonesia: Investigation Nos. 731-TA-1229-1230 (Second Review). By order of the Commission. Issued: May 1, 2026. Lisa Barton, Secretary to the Commission. Footnotes 1.  The record is defined in § 207.2(f) of the Commission's Rules of Practice and Procedure ( 19 CFR 207.2(f) ). Back to Citation 2.  Due to the lapse in appropriations and ensuing cessation of Commission oper…